Pooled Analysis of Randomized Trials Comparing Drug Efficacy for Early COVID-19 During Omicron Waves
Background: Antivirals and monoclonal antibodies are largely used for early treatment of COVID-19 in high-risk people, based on data from randomized trials (RCTs) among unvaccinated people before the omicron era. No evidence from RCTs is available on the comparison of clinical efficacy of currently available treatments. We present a pooled analysis of two RCTs conducted…